NCT05040412 is a NA clinical trial of difficult laryngoscopy in Diabetes Mellitus, sponsored by Bagcilar Training and Research Hospital.

Who is sponsoring NCT05040412?

NCT05040412 is sponsored by Bagcilar Training and Research Hospital.

What drugs are being tested in NCT05040412?

Interventions in NCT05040412: difficult laryngoscopy.

What condition does NCT05040412 study?

NCT05040412 studies Diabetes Mellitus.

Is NCT05040412 still recruiting?

NCT05040412 is currently completed. Last updated 10 September 2021.

Last reviewed 2021-09-10 · How we verify

NCT05040412

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of the Patients With Diabetes Mellitus Using Either Insulin or Oral Antidiabetic Drug In Terms Of Difficult Laryngoscopy

Completed NA Last updated 10 September 2021

What this trial tests

NA trial testing difficult laryngoscopy in Diabetes Mellitus in 192 participants. Completed in 15 May 2020.

Timeline

25 January 2020

Primary endpoint
30 April 2020

15 May 2020

Quick facts

Lead sponsor	Bagcilar Training and Research Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	192
Start date	25 January 2020
Primary completion	30 April 2020
Estimated completion	15 May 2020
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

difficult laryngoscopy

Conditions studied

Diabetes Mellitus — all drugs for Diabetes Mellitus →

Sponsor

Bagcilar Training and Research Hospital

Who can join

Adults 18 to 90, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Diabetes Mellitus is known to be a risk factor for difficult laryngoscopy. Several studies showed that diabetes mellitus is responsible for 30% of difficult laryngoscopy.Insulin and oral antidiabetic drugs are two main current medication prescribed for diabetes patients.Insulin is responsible for muscle hypertrophy and weigh gain.Oral antidiabetic drugs induces muscle atrophy. The aim of this study is to evaluate the differences in the difficult laryngoscopy as a general anesthetic component in patients with Diabetes Mellitus (DM) using either insulin or oral antidiabetic drug (OAD).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus

Currently open trials in the same condition.

NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting

Other Bagcilar Training and Research Hospital trials

Trials by the same sponsor.

NCT07164248 — Evaluation of Bone Mineral Density Indications and Outcomes in Female Adolescents: Implications for Early Detection of O · completed
NCT07186127 — Methotrexate Treatment in Cases of Ectopic Pregnancy With Relative Contraindications · recruiting
NCT06515028 — Effects of Anesthesia Technique on Endothelial Function · NA · not yet recruiting
NCT06497634 — Effect of Spinal Needle Type on Optic Nerve Sheath Diameter · NA · not yet recruiting
NCT06970821 — Association of Vitamin D Status With Metabolic Markers in Adolescents With Polycystic Ovary Syndrome · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05040412 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bagcilar Training and Research Hospital
Last refreshed: 10 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05040412.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing